Your browser doesn't support javascript.
loading
Exenatide once weekly versus placebo in Parkinson's disease: a randomised, double-blind, placebo-controlled trial.
Athauda, Dilan; Maclagan, Kate; Skene, Simon S; Bajwa-Joseph, Martha; Letchford, Dawn; Chowdhury, Kashfia; Hibbert, Steve; Budnik, Natalia; Zampedri, Luca; Dickson, John; Li, Yazhou; Aviles-Olmos, Iciar; Warner, Thomas T; Limousin, Patricia; Lees, Andrew J; Greig, Nigel H; Tebbs, Susan; Foltynie, Thomas.
Afiliación
  • Athauda D; Sobell Department of Motor Neuroscience, University College London Institute of Neurology and the National Hospital for Neurology and Neurosurgery, London, UK.
  • Maclagan K; Comprehensive Clinical Trials Unit, University College London, London, UK.
  • Skene SS; Comprehensive Clinical Trials Unit, University College London, London, UK.
  • Bajwa-Joseph M; Comprehensive Clinical Trials Unit, University College London, London, UK.
  • Letchford D; Comprehensive Clinical Trials Unit, University College London, London, UK.
  • Chowdhury K; Comprehensive Clinical Trials Unit, University College London, London, UK.
  • Hibbert S; Comprehensive Clinical Trials Unit, University College London, London, UK.
  • Budnik N; Leonard Wolfson Experimental Neuroscience Centre, London, UK.
  • Zampedri L; Leonard Wolfson Experimental Neuroscience Centre, London, UK.
  • Dickson J; Institute of Nuclear Medicine, University College London Hospitals NHS Trust, London, UK.
  • Li Y; Translational Gerontology Branch, Intramural Research Program, National Institute on Aging, National Institutes of Health, Baltimore, MD, USA.
  • Aviles-Olmos I; Sobell Department of Motor Neuroscience, University College London Institute of Neurology and the National Hospital for Neurology and Neurosurgery, London, UK.
  • Warner TT; Queen Square Brain Bank, London, UK.
  • Limousin P; Sobell Department of Motor Neuroscience, University College London Institute of Neurology and the National Hospital for Neurology and Neurosurgery, London, UK.
  • Lees AJ; Sobell Department of Motor Neuroscience, University College London Institute of Neurology and the National Hospital for Neurology and Neurosurgery, London, UK.
  • Greig NH; Translational Gerontology Branch, Intramural Research Program, National Institute on Aging, National Institutes of Health, Baltimore, MD, USA.
  • Tebbs S; Comprehensive Clinical Trials Unit, University College London, London, UK.
  • Foltynie T; Sobell Department of Motor Neuroscience, University College London Institute of Neurology and the National Hospital for Neurology and Neurosurgery, London, UK. Electronic address: t.foltynie@ucl.ac.uk.
Lancet ; 390(10103): 1664-1675, 2017 Oct 07.
Article en En | MEDLINE | ID: mdl-28781108
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enfermedad de Parkinson / Péptidos / Ponzoñas Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Año: 2017 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enfermedad de Parkinson / Péptidos / Ponzoñas Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Año: 2017 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Reino Unido